SFX by Ex Libris Inc.

Title:	Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Source:	Nature [0028-0836] Warren, T K yr:2014

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Zhu, Michael X. "NAADP mobilizes calcium from acidic organelles through two-pore channels." Nature 459.7246 (2009): 596-600.
description	2.	Bausch, Daniel G. "Assessment of the Risk of Ebola Virus Transmission from Bodily Fluids and Fomites." The journal of infectious diseases 196.2 (2007): 142-7.
description	3.	De, E. "Antiviral drugs in current clinical use." Journal of clinical virology 30.2 (2004): 115-33.
description	4.	Tannock, Megan A. "Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions." Journal of medical virology 84.1: 170-181.
description	5.	Crance, Jean Marc M. "Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses." Antiviral research 58.1 (2003): 73-9.
description	6.	Ruas, T. "TPC2 Is a Novel NAADP-sensitive Ca2+ Release Channel, Operating as a Dual Sensor of Luminal pH and Ca2+." Journal of biological chemistry 285.45 (2010): 35039-35046.
description	7.	Pourrut, X. "Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species." The journal of infectious diseases 196.Suppl. 2 (2007): 176-83.
description	8.	Formenty, P. "Detection of Ebola Virus in Oral Fluid Specimens during Outbreaks of Ebola Virus Hemorrhagic Fever in the Republic of Congo." Clinical infectious diseases 42.11 (2006): 1521-1526.
description	9.	Guse, A. "Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling and arrhythmias in the heart evoked by β-adrenergic stimulation." Journal of biological chemistry 288.22 (2013): 16017-30.
description	10.	Collins, Thomas P. "NAADP influences excitation-contraction coupling by releasing calcium from lysosomes in atrial myocytes." Cell calcium 50.5 (2011): 449-58.
description	11.	Sagripanti, J. "Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces." Archives of virology 156.3 (2011): 489-494.
description	12.	Rowe, A K K. "Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit." The journal of infectious diseases 179.1 (1999): 28-35.
description	13.	Forgac, S. "Three-dimensional structure of the vacuolar ATPase proton channel by electron microscopy." The Journal of biological chemistry 276.47 (2001): 44064-8.
description	14.	De Clercq, E. "Emerging antiviral drugs." Expert Opinion on Emerging Drugs 13.3 (2008): 393-416.
description	15.	Rakovic, S. "A specific cyclic ADP-ribose antagonist inhibits cardiac excitation-contraction coupling." Current biology 6.8 (1996): 989-96.
description	16.	Bausch, Daniel G. "Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions." Antiviral research 78.1 (2008): 150-61.
description	17.	De Clercq, E. "Antiviral drugs: current state of the art." Journal of clinical virology 22.1: 73-89.
description	18.	Hsieh, H. "Strategies of Development of Antiviral Agents Directed Against Influenza Virus Replication." Current pharmaceutical design 13.34 (2007): 3531-3542.
description	19.	Villalain, J. "Membranotropic Effects of Arbidol, a Broad Anti-Viral Molecule, on Phospholipid Model Membranes." The journal of physical chemistry. B 114.25 (2010): 8544-8554.
description	20.	Zarranz, B. "Antiplasmodial activity of 3-trifluoromethyl-2-carbonylquinoxaline di-N-oxide derivatives." RBCF. Revista Brasileira de Ciências Farmacêuticas 42.3 (2006): 357-.